Compare IDEXX Laboratories, Inc. (IDXX) vs iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs iShares iBoxx $ Inv Grade Corporate Bond ETF — how do they compare? IDEXX Laboratories, Inc. trades at $543.91 (market cap $43.58B), while iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $106.68. The key difference: IDEXX Laboratories, Inc. is trading nearer its 52-week high, iShares iBoxx $ Inv Grade Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| IDXX | LQD | |
|---|---|---|
Market Cap | $43.58B | — |
Sector | Health | — |
52-Week High | $766.68 | $112.91 |
52-Week Low | $526.44 | $106.85 |
Enterprise Value | $44.48B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories trades at $552.46, down 2.64% today, with neutral technical signals but strong fundamental performance. The company maintains robust profitability with 24.63% net margins and has beaten earnings expectations for three consecutive quarters. Recent news highlights AI integration in medical devices and upcoming Q2 2026 results on August 4, 2026. The stock shows consistent revenue growth from $3.4B in 2022 to $4.3B in 2025.
Outlook remains positive given earnings momentum and analyst consensus, though elevated valuation ratios (P/E 41.49) pose risks. Key catalysts include Q2 earnings release and continued AI adoption in veterinary diagnostics. Primary risks involve competitive pressures and market volatility affecting premium valuations.
LQD trades at $107.15, down 0.38% on the day, with technical indicators showing a bearish trend from moving averages while oscillators are neutral. The ETF maintains a consistent dividend schedule, with recent payments around $0.40-0.42 per share. Market sentiment is mixed amid Federal Reserve uncertainty and shifting bond flows.
The outlook for LQD hinges on interest rate direction and corporate bond demand. Opportunities exist for income-focused investors seeking investment-grade exposure, but risks include potential Fed rate hikes and economic volatility that could pressure bond prices. Current technical weakness suggests cautious near-term positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About iShares iBoxx $ Inv Grade Corporate Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →
